Long-term outcomes after treatment of in-stent restenosis using the Absorb everolimus-eluting bioresorbable scaffold

QR Code

Long-term outcomes after treatment of in-stent restenosis using the Absorb everolimus-eluting bioresorbable scaffold

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Stefan Toggweiler, Matthias Bossard, Florim Cuculi, Federico Moccetti, Mathias Wolfrum, Richard Kobza, Adrian Attinger-Toller, Mehdi Madanchi, Giacomo Maria Cioffi, Thomas Seiler, Luca Vercelli, Philipp Burkart
Format:	article
Langue:	EN
Publié:	BMJ Publishing Group 2021
Sujets:	Diseases of the circulatory (Cardiovascular) system RC666-701
Accès en ligne:	https://doaj.org/article/33b409893709413c9d06b7331e6556d7
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Comparison of the everolimus-eluting bioresorbable vascular scaffold versus the everolimus-eluting metallic stent in real-world patients with ST-segment elevation myocardial infarction
par: Piotr Desperak, et autres
Publié: (2020)

Everolimus-eluting coronary stents
par: Alejandro Saez, et autres
Publié: (2010)

Long-term comparison of everolimus- vs. novolimus-eluting bioresorbable vascular scaffolds in real world patients
par: Beytullah Cakal, et autres
Publié: (2020)

Everolimus-eluting stents: update on current clinical studies
par: Allocco DJ, et autres
Publié: (2011)

Everolimus-eluting stent platforms in percutaneous coronary intervention: comparative effectiveness and outcomes
par: Panoulas VF, et autres
Publié: (2015)

Coronary Endothelium‐Dependent Vasomotor Function After Drug‐Eluting Stent and Bioresorbable Scaffold Implantation
par: Josep Gomez‐Lara, et autres
Publié: (2021)

Absorb BRS for in-stent restenosis: the final bow before (scaffold) collapse?
par: Stéphane Cook, et autres
Publié: (2021)

A novel platinum chromium everolimus-eluting stent for the treatment of coronary artery disease
par: Bennett J, et autres
Publié: (2013)

The everolimus-eluting Xience stent in small vessel disease: bench, clinical, and pathology view
par: Sanchez OD, et autres
Publié: (2014)

Computational and experimental mechanical performance of a new everolimus-eluting stent purpose-built for left main interventions
par: Saurabhi Samant, et autres
Publié: (2021)

Comparison of Drug-Coated Balloon Angioplasty vs. Drug-Eluting Stent Implantation for Drug-Eluting Stent Restenosis in the Routine Clinical Practice: A Meta-Analysis of Randomized Controlled Trials
par: Yong Zhu, et autres
Publié: (2021)

Novel Polymer-Free Everolimus-Eluting Stent Fabricated using Femtosecond Laser Improves Re-endothelialization and Anti-inflammation
par: In-Ho Bae, et autres
Publié: (2018)

Pathological findings after third- and second-generation everolimus-eluting stent implantations in coronary arteries from autopsy cases and an atherosclerotic porcine model
par: Suguru Migita, et autres
Publié: (2021)

Restenosis After Tack Implantation is Associated with Less Complex Patterns of Restenosis Compared to Stent Implantation
par: Raghu Kolluri, et autres
Publié: (2020)

Pathogenesis and Clinical Significance of In-Stent Restenosis in Patients with Diabetes
par: Grzegorz K. Jakubiak, et autres
Publié: (2021)

Long-term outcomes of Absorb bioresorbable vascular scaffold using predilation, sizing, and postdilation protocol in a real-world patient population
par: Sinem Çakal, et autres
Publié: (2021)

Impact of anemia on in-stent restenosis after percutaneous coronary intervention
par: Huilin Hu, et autres
Publié: (2021)

Factors affecting in-stent restenosis after angioplasty with the Enterprise stent for intracranial atherosclerotic diseases
par: Kun Zhang, et autres
Publié: (2021)

Early scaffold strut coverage in ultra-high molecular weight amorphous PLLA sirolimus-eluting bioresorbable scaffolds: impact of strut thickness assessed in normal porcine coronary arteries
par: Paweł Gąsior, et autres
Publié: (2020)

Bioresorbable scaffolds in the treatment of coronary artery disease
par: Zhang Y, et autres
Publié: (2013)

Corrigendum to “A novel mechanism of inhibiting in-stent restenosis with arsenic trioxide drug-eluting stent: Enhancing contractile phenotype of vascular smooth muscle cells via YAP pathway” [Bioact. Mater. 6 2 (February 2021) 375–385]
par: Yinping Zhao, et autres
Publié: (2022)

Biodegradable Cable-Tie Rapamycin-eluting Stents
par: Cheng-Hung Lee, et autres
Publié: (2017)

Blood biomarkers of progressive atherosclerosis and restenosis after stenting of symptomatic intracranial artery stenosis
par: Melanie Haidegger, et autres
Publié: (2021)

A better effect of cilostazol for reducing in-stent restenosis after femoropopliteal artery stent placement in comparison with ticlopidine
par: Ikushima I, et autres
Publié: (2011)

Bioresorbable vascular scaffolds technology: current use and future developments
par: Giacchi G, et autres
Publié: (2016)

New drug-eluting stents: technological refinement continues
par: Javier Suárez de Lezo, et autres
Publié: (2021)

A case of in stent restenosis (ISR) treated with drug-coated balloons (DCB) in a young diabetic with multiple stents
par: Tutan Das, et autres
Publié: (2021)

Clonal diversity of the B cell receptor repertoire in patients with coronary in-stent restenosis and type 2 diabetes
par: Weng Ruiqiang, et autres
Publié: (2021)

IN STENT RESTENOSIS (ISR) IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (PCI) FOR CORONARY ARTERY DISEASE (CAD)
par: Waseem Raja, et autres
Publié: (2020)

Iterative reconstruction improves detection of in-stent restenosis by high-pitch dual-source coronary CT angiography
par: Junjie Yang, et autres
Publié: (2017)

High coronary calcium score and post-procedural CK-MB are noninvasive predictors of coronary stent restenosis
par: Lee JB, et autres
Publié: (2017)

Promoting vascular healing using nanofibrous ticagrelor-eluting stents
par: Lee CH, et autres
Publié: (2018)

Long-term effectiveness and safety of sirolimus drug-eluting stents
par: Bikkina M, et autres
Publié: (2011)

Head-to-head comparison of sirolimus-eluting stents versus paclitaxel-eluting stents in patients undergoing percutaneous coronary intervention: a meta-analysis of 76 studies.
par: Xinlin Zhang, et autres
Publié: (2014)

Prophylactic paclitaxel-eluting stent placement does not improve covered femoropopliteal stent patency
par: Rory Marples, MBBS, et autres
Publié: (2022)

Preclinical evaluation of sorafenib-eluting stent for suppression of human cholangiocarcinoma cells
par: Kim DH, et autres
Publié: (2013)

Next generation drug-eluting stents: focus on bioabsorbable platforms and polymers
par: Brendan Doyle, et autres
Publié: (2009)

Saphenous Vein Graft Aneurysm after Drug-Eluting Stent Implantation: Treatment by Covered Stent
par: Kyriacos Papadopoulos, et autres
Publié: (2021)

Advances in drug eluting stents &ndash; focus on the Endeavor&reg; zotarolimus stent
par: Jonathan Bridges, et autres
Publié: (2008)

Optical computed tomography (OCT) guided follow up of primary PCI patients for predicting factors for restenosis and late stent malapposition
par: Swati Sharma, et autres
Publié: (2021)